Biogen, Inc. (BIIB)
218.07
+2.64
(+1.23%)
USD |
NASDAQ |
Sep 11, 13:46
Biogen Gross Profit (TTM) : 6.211B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.211B |
| March 31, 2026 | 6.364B |
| December 31, 2025 | 6.350B |
| September 30, 2025 | 6.394B |
| June 30, 2025 | 6.37B |
| March 31, 2025 | 6.256B |
| December 31, 2024 | 6.243B |
| September 30, 2024 | 6.254B |
| June 30, 2024 | 6.350B |
| March 31, 2024 | 6.343B |
| December 31, 2023 | 6.389B |
| September 30, 2023 | 6.530B |
| June 30, 2023 | 6.583B |
| March 31, 2023 | 6.729B |
| December 31, 2022 | 6.650B |
| September 30, 2022 | 6.760B |
| June 30, 2022 | 7.061B |
| March 31, 2022 | 7.369B |
| December 31, 2021 | 7.761B |
| September 30, 2021 | 6.299B |
| June 30, 2021 | 6.850B |
| March 31, 2021 | 7.633B |
| December 31, 2020 | 8.359B |
| September 30, 2020 | 10.73B |
| June 30, 2020 | 10.84B |
| Date | Value |
|---|---|
| March 31, 2020 | 10.62B |
| December 31, 2019 | 10.44B |
| September 30, 2019 | 10.33B |
| June 30, 2019 | 10.19B |
| March 31, 2019 | 10.00B |
| December 31, 2018 | 9.855B |
| September 30, 2018 | 9.659B |
| June 30, 2018 | 9.416B |
| March 31, 2018 | 9.188B |
| December 31, 2017 | 8.570B |
| September 30, 2017 | 8.580B |
| June 30, 2017 | 8.430B |
| March 31, 2017 | 8.288B |
| December 31, 2016 | 8.644B |
| September 30, 2016 | 8.605B |
| June 30, 2016 | 8.468B |
| March 31, 2016 | 8.216B |
| December 31, 2015 | 8.015B |
| September 30, 2015 | 7.880B |
| June 30, 2015 | 7.703B |
| March 31, 2015 | 7.587B |
| December 31, 2014 | 7.258B |
| September 30, 2014 | 6.388B |
| June 30, 2014 | 5.778B |
| March 31, 2014 | 5.185B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | 835.84M |
| AbbVie, Inc. | 45.98B |
| Regeneron Pharmaceuticals, Inc. | 12.65B |
| Vertex Pharmaceuticals, Inc. | 10.94B |
| Amgen, Inc. | 27.78B |